e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Aetiology and outcomes of infective exacerbations of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Vitamin D, innate immunity and outcomes in pneumonia and exacerbations of COPD
L. Leow, T. Simpson, R. Cursons, N. Karalus, R. Hancox (Hamilton, Dunedin, New Zealand)
Source:
Annual Congress 2010 - Aetiology and outcomes of infective exacerbations of COPD
Session:
Aetiology and outcomes of infective exacerbations of COPD
Session type:
Oral Presentation
Number:
3848
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Leow, T. Simpson, R. Cursons, N. Karalus, R. Hancox (Hamilton, Dunedin, New Zealand). Vitamin D, innate immunity and outcomes in pneumonia and exacerbations of COPD. Eur Respir J 2010; 36: Suppl. 54, 3848
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Vitamin D, exacerbations and hospitalizations in COPD patients
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Vitamin D deficiency and COPD exacerbations: Effect of vitamin D supplementation
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015
Is vitamin D deficiency a risk factor for COPD exacerbations?
Source: Annual Congress 2013 –Environment and lifestyle: associations with respiratory disease
Year: 2013
Altered inflammasome activity in bacterial acute exacerbations of COPD (AECOPD)
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013
Vitamin D status in COPD patients admitted for exacerbation
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015
Distinguishing features of pneumonia and exacerbations in COPD
Source: International Congress 2015 – Prognostic factors in pneumonia: from clinical observations to experimental models
Year: 2015
Pneumonic and non-pneumonic exacerbations of COPD: Systemic inflammatory response and clinical characteristics
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Predictive factors of 90-days post-discharge COPD acute exacerbation’s recurrence
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016
Serum SP-A and SP-D levels in patients admitted to the hospital with acute COPD exacerbation
Source: International Congress 2016 – Inflammatory biomarkers in airway diseases
Year: 2016
Recording and response to hyperglycaemia in patients presenting with infective exacerbations of COPD
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Late Breaking Abstract: Vitamin D deficiency linked to sepsis in COPD with acute infective exacerbations
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
The role of bacterial infections in COPD exacerbations
Source: Eur Respir J 2005; 26: Suppl. 49, 298s
Year: 2005
Eosinophilia as marker of outcome in hospitalised patients with AECOPD
Source: Annual Congress 2013 –COPD and infections
Year: 2013
Treatment of infection in COPD exacerbations
Source: International Congress 2014 – PG16 Low respiratory tract infections: learning from real clinical cases
Year: 2014
LATE-BREAKING ABSTRACT: Effect of vitamin D on inflammatory and antibacterial responses to cigarette smoke
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015
Does sputum, biochemical and radiological markers of infection correlate with antibiotic prescribing in acute exacerbations of COPD?
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Evaluation of vitamin D levels in COPD and its correlation with disease severity and frequency of exacerbations
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
Can vitamin D
3
supplementation reduce the time to severe asthma exacerbations in children with asthma?
Source: Breathe, 17 (3) 210071; 10.1183/20734735.0071-2021
Year: 2021
Does vitamin D deficiency worsen the hospital outcome in patients with acute exacerbation COPD?
Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD
Year: 2018
Etiology of exacerbations in severe COPD patients with bronchial chronic colonization by pseudomonas
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept